SAVAYSA (Daiichi Sankyo, Inc.)
Welcome to the PulseAid listing for the SAVAYSA drug offered from Daiichi Sankyo, Inc.. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Daiichi Sankyo, Inc. |
NON-PROPRIETARY NAME: | EDOXABAN TOSYLATE |
SUBSTANCE NAME: | EDOXABAN TOSYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-01-12 |
END MARKETING DATE: | 0000-00-00 |
SAVAYSA HUMAN PRESCRIPTION DRUG Details:
Item Description | SAVAYSA from Daiichi Sankyo, Inc. |
LABELER NAME: | Daiichi Sankyo, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15(mg/1) |
START MARKETING DATE: | 2015-01-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65597-201_0b27d664-baa2-4208-ab84-2b8735daceec |
PRODUCT NDC: | 65597-201 |
APPLICATION NUMBER: | NDA206316 |
Other EDOXABAN TOSYLATE Pharmaceutical Manufacturers / Labelers: